Key Takeaways: Medicaid and CHIP Funding Restrictions Are Scheduled to Begin

A federal rule restricting Medicaid and CHIP payment and federal funding for specified gender-affirming treatment for young people is scheduled to take effect October 13, 2026. It applies to Medicaid beneficiaries under 18 and separate CHIP beneficiaries under 19. Litigation is ongoing. The court records reviewed for this brief do not establish that the rule has been blocked nationwide.

• Confirm Coverage Promptly: Ask your treating clinic, insurer, and state Medicaid or CHIP agency how the rule affects your specific treatment, prescriptions, and upcoming appointments. Request written answers.

• Do Not Assume a Lawsuit Pauses the Rule: A New Hampshire court denied a temporary restraining order request on October 5. A separate state lawsuit remains pending. A later order could change the situation.

• The Transition Provision Is Limited: The rule permits federal funding for certain existing hormone therapy for up to six months as a tapering provision. It does not guarantee six months of unchanged care for every patient or cover every treatment.

• Keep Your Care Team Involved: Ask your clinician about continuity of care and any medically appropriate next steps. Do not change prescribed treatment on your own because of a headline.

• Check Alternatives Individually: The rule allows states to use state-only funds outside federally matched Medicaid or CHIP. Availability depends on the state, program, provider, and treatment.

Read more on our website OR check out the following links: Review the CMS announcement, the final-rule document, and the October 5 court order.

This newsletter provides general information, not medical or legal advice. Coverage and court orders can change; confirm your circumstances with your care team and qualified legal support.